Clinical Trial Update: An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia [Phase 3]

View source ↗

Summary

Phase 3 trial investigating SM-1 for transient insomnia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transient Insomnia

Drugs mentioned

• SM-1

Snippet

Sponsor: Sequential Medicine Ltd | Conditions: Transient Insomnia | Phase 3 | Status: WITHDRAWN